Identifying requirements for RSK2 specific inhibitors.

Eric B Wright, Shinji Fukuda, Mingzong Li, Yu Li, George A O'Doherty, Deborah A Lannigan

Journal of enzyme inhibition and medicinal chemistry 2021 Dec

filter terms:

Identifying isoform-specific inhibitors for closely related kinase family members remains a substantial challenge. The necessity for achieving this specificity is exemplified by the RSK family, downstream effectors of ERK1/2, which have divergent physiological effects. The natural product, SL0101, a flavonoid glycoside, binds specifically to RSK1/2 through a binding pocket generated by an extensive conformational rearrangement within the RSK N-terminal kinase domain (NTKD). In modelling experiments a single amino acid that is divergent in RSK3/4 most likely prevents the required conformational rearrangement necessary for SL0101 binding. Kinetic analysis of RSK2 association with SL0101 and its derivatives identified that regions outside of the NTKD contribute to stable inhibitor binding. An analogue with an n-propyl-carbamate at the 4" position on the rhamnose moiety was identified that forms a highly stable inhibitor complex with RSK2 but not with RSK1. These results identify a SL0101 modification that will aid the identification of RSK2 specific inhibitors.

Citation

Eric B Wright, Shinji Fukuda, Mingzong Li, Yu Li, George A O'Doherty, Deborah A Lannigan. Identifying requirements for RSK2 specific inhibitors. Journal of enzyme inhibition and medicinal chemistry. 2021 Dec;36(1):1798-1809